In conclusion, myotubes from p.P50T/AKT2 variant carriers show multiple signalling alterations which may contribute to predisposition to insulin resistance and T2D in the carriers of this signalling variant. This evidence concerns the gene AKT2 and type 2 diabetes mellitus.